Eyk Van Otterloo
Eyk Van Otterloo is a prominent figure in the world of finance and investments, particularly known for his success in asset management and philanthropy. He is the Co-Founder of Grantham, Mayo, & Van Otterloo, a value-oriented investment management firm. At GMO, he focused on applying a disciplined, research-driven approach to investing, emphasizing long-term value creation and risk management. Eyk is considered among the most important collectors of seventeenth-century Dutch and Flemish art in the United States. Over the past 35 years, Eyk and his wife have acquired an unparalleled private collection, representing a selection of work by the Dutch Golden Age’s most important artists. They also support local and international organizations in education, medicine, and the arts.
Eyk Van Otterloo Professional Experience / Academic History
Professional Experience
-
Founding Member
Academic History
-
M.B.A.
COMMUNITY INVOLVEMENT
Marblehead/Swampscott YMCA
Peabody Essex Museum
United World Colleges
FINANCIAL CAREER
Eyk co-founded GMO alongside Jeremy Grantham and Richard Mayo.
He contributed to the firm's reputation for disciplined investment strategies grounded in rigorous research and a focus on long-term value creation.
Before GMO’s founding in 1977, he managed investments at Phoenix Mutual Life Investment Company and Keystone Custodian Funds.
A member of the GMO Board and of the Chemonics Board since 1999, he became the majority shareholder for Chemonics in 2006.
Eyk and his wife's collection includes major artworks by artists such as Rembrandt, Gerrit Dou, Gerrit van Honthorst, Saenredam and Jacob van Ruisdael.
Recently, they decided to give their collection to the Museum of Fine Arts in Boston, including highlights such as Rembrandt’s Portrait of Aeltje Uylenburgh and Dog at Rest by Gerrit Dou.
PHILANTHROPY
Eyk and his wife have made significant donations to various causes, including education, healthcare and the arts.
Their philanthropic efforts often focus on supporting organizations that promote social welfare and cultural enrichment.
They have also contributed to healthcare causes, funding research and programs that aim to improve medical treatments and patient care.